|
Aug 7
|
Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 5
|
Clearside Biomedical, Inc. (CLSD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Jul 25
|
Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2024 Financial Results and Pipeline Update
|
|
Jun 2
|
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer
|
|
Jun 1
|
Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers
|
|
May 31
|
It's Unlikely That Arcus Biosciences, Inc.'s (NYSE:RCUS) CEO Will See A Huge Pay Rise This Year
|
|
May 12
|
Arcus Biosciences, Inc. (NYSE:RCUS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
|
|
May 10
|
Arcus Biosciences Surpasses Analyst Revenue Forecasts in Q1 2024
|
|
May 10
|
Arcus Biosciences First Quarter 2024 Earnings: Beats Expectations
|
|
May 9
|
Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Arcus Biosciences Inc (RCUS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
|
|
May 8
|
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 8
|
Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update
|
|
May 2
|
Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024
|
|
May 2
|
Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
May 1
|
Will Arcus Biosciences, Inc. (RCUS) Report Negative Earnings Next Week? What You Should Know
|
|
Apr 24
|
Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting
|
|
Apr 23
|
Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update
|
|
Apr 1
|
Investors bid Arcus Biosciences (NYSE:RCUS) up US$219m despite increasing losses YoY, taking five-year CAGR to 8.1%
|
|
Mar 29
|
Insider Sell: COO Jennifer Jarrett Sells 11,551 Shares of Arcus Biosciences Inc (RCUS)
|